摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-(2-Chlorophenyl)-3-(2-fluorophenyl)-2,3-dihydrothiazolo[3,2-C]pyrimidine-5,7-(6H)-dione | 496927-36-7

中文名称
——
中文别名
——
英文名称
8-(2-Chlorophenyl)-3-(2-fluorophenyl)-2,3-dihydrothiazolo[3,2-C]pyrimidine-5,7-(6H)-dione
英文别名
8-(2-chlorophenyl)-3-(2-fluorophenyl)-2,3-dihydro-[1,3]thiazolo[3,2-c]pyrimidine-5,7-dione
8-(2-Chlorophenyl)-3-(2-fluorophenyl)-2,3-dihydrothiazolo[3,2-C]pyrimidine-5,7-(6H)-dione化学式
CAS
496927-36-7
化学式
C18H12ClFN2O2S
mdl
——
分子量
374.823
InChiKey
FPOQSUCKDNUWII-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.54±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    25
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    74.7
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    8-(2-Chlorophenyl)-3-(2-fluorophenyl)-2,3-dihydrothiazolo[3,2-C]pyrimidine-5,7-(6H)-dione三苯基膦三氟乙酸偶氮二甲酸二乙酯 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 生成 6-[(2R)-2-amino-2-phenylethyl]-8-(2-chlorophenyl)-3-(2-fluorophenyl)-2,3-dihydro-[1,3]thiazolo[3,2-c]pyrimidine-5,7-dione
    参考文献:
    名称:
    Efficient synthesis of bicyclic oxazolino- and thiazolino[3,2-c]pyrimidine-5,7-diones and its application to the synthesis of GnRH antagonists
    摘要:
    Treatment of various 2-methyl oxazolines or thiazolines with chlorocarbonyl isocyanate gives the corresponding bicyclic oxazolino- or thiazolino[3,2-c]pyrimidin-5,7-dione derivatives in very good yield. This reaction has been applied to the rapid syntheses of human gonadotropin-releasing hormone (hGnRH) receptor antagonists for SAR study, resulting in 13e with binding affinity in the low nanomolar range (4.5 nM). (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.01.009
  • 作为产物:
    描述:
    2-(2-chlorophenyl)-4-(2-fluorophenyl)-4,5-dihydrothiazoleN-(氯甲酰)异氰酸酯二氯甲烷N,N-二甲基苯胺 为溶剂, 以67%的产率得到8-(2-Chlorophenyl)-3-(2-fluorophenyl)-2,3-dihydrothiazolo[3,2-C]pyrimidine-5,7-(6H)-dione
    参考文献:
    名称:
    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
    摘要:
    GnRH受体拮抗剂已被披露,对男性和女性的各种与性激素有关的疾病具有治疗作用。本发明的化合物具有以下结构:其中A、R1、R2、R3a、R3b、R4、R5、R6和n的定义如本文所述,包括立体异构体、前药和其药用可接受的盐。还披露了含有本发明化合物的组合物与药用可接受载体,以及与使用该化合物在需要的受试者中拮抗促性腺激素释放激素相关的方法。
    公开号:
    US20030109535A1
点击查看最新优质反应信息

文献信息

  • US6740656B2
    申请人:——
    公开号:US6740656B2
    公开(公告)日:2004-05-25
  • Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
    申请人:Neurocrine Biosciences, Inc.
    公开号:US20030109535A1
    公开(公告)日:2003-06-12
    GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: 1 wherein A, R 1 , R 2 , R 3a , R 3b , R 4 , R 5 , R 6 , and n are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.
    GnRH受体拮抗剂已被披露,对男性和女性的各种与性激素有关的疾病具有治疗作用。本发明的化合物具有以下结构:其中A、R1、R2、R3a、R3b、R4、R5、R6和n的定义如本文所述,包括立体异构体、前药和其药用可接受的盐。还披露了含有本发明化合物的组合物与药用可接受载体,以及与使用该化合物在需要的受试者中拮抗促性腺激素释放激素相关的方法。
  • Efficient synthesis of bicyclic oxazolino- and thiazolino[3,2-c]pyrimidine-5,7-diones and its application to the synthesis of GnRH antagonists
    作者:Joseph Pontillo、Chen Chen
    DOI:10.1016/j.bmcl.2005.01.009
    日期:2005.3
    Treatment of various 2-methyl oxazolines or thiazolines with chlorocarbonyl isocyanate gives the corresponding bicyclic oxazolino- or thiazolino[3,2-c]pyrimidin-5,7-dione derivatives in very good yield. This reaction has been applied to the rapid syntheses of human gonadotropin-releasing hormone (hGnRH) receptor antagonists for SAR study, resulting in 13e with binding affinity in the low nanomolar range (4.5 nM). (c) 2005 Elsevier Ltd. All rights reserved.
查看更多